Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments

This publication has 18 references indexed in Scilit:

• SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINISING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA
  The Lancet, 1982
• Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancer
  Reproduction, 1982
• Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
  Proceedings of the National Academy of Sciences, 1982
• From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents.
  1982
• Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
  Proceedings of the National Academy of Sciences, 1981
• Hypothalamic-pituitary-testicular function in rats after supraphysiological doses of a highly active LRH analogue (buserelin)
  Acta Endocrinologica, 1980
• THE IMPORTANCE OF PITUITARY TUMOUR SIZE IN PATIENTS WITH HYPERPROLACTINAEMIA IN RELATION TO HORMONAL VARIABLES AND EXTRASELLAR EXTENSION OF TUMOUR
  Clinical Endocrinology, 1980
• Pituitary Gonadotropin Inhibition by a Highly Active Analog of Luteinizing Hormone-Releasing Hormone
  Fertility and Sterility, 1978
• Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Histological and endocrine studies
  Published by Elsevier ,1977
• REGRESSION OF RAT MAMMARY-TUMORS EFFECTED BY A GONADOLIBERIN ANALOG
  1976